Avalyn Pharma Ord Shs (Proposed)

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Avalyn Pharma Ord Shs (Proposed) had 92.31M in cash and cash equivalents.

Avalyn Pharma Ord Shs (Proposed) reported 15.32M in total liabilities as of the latest reported quarter, including 14.09M in current liabilities and 1.23M in non-current liabilities.

As of the latest reported quarter, Avalyn Pharma Ord Shs (Proposed)'s total assets were 148.88M, consisting of 143.56M in current assets and 5.32M in non-current assets.

Avalyn Pharma Ord Shs (Proposed) reported 133.56M in total shareholders' equity as of the latest reported quarter.